25 Considerations in Preparing For an IPO: Healthcare & Life Sciences Companies
1. Experienced advisors Choose experienced advisors, including lawyers, auditors and financial consultants (if necessary), and get them involved early. Advisors who work routinely with the SEC and investment bankers and each other will help proactively identify key issues, expedite the transaction and avoid the pitfalls that can delay offerings, create […]
Practical Observations on Preparing Prospectuses Under the New Prospectus Regulation
On 21 July 2019 the new Prospectus Regulation (Regulation (EU) 2017/1129) (the “œNew Prospectus Regulation “) regime repealed and replaced the previous Prospectus Directive ( “œPD2 “) regime in all EU Member States. In this briefing we explore the impact of the New Prospective Regulation on issuers producing a prospectus […]